Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
- PMID: 23067918
- PMCID: PMC3474978
- DOI: 10.1016/j.ahj.2012.06.017
Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
Abstract
Background: Peripheral arterial disease increases cardiovascular risk in many patient populations. The risks associated with an abnormal ankle-brachial index (ABI) in patients with type 2 diabetes and stable coronary artery disease have not been well described with respect to thresholds and types of cardiovascular events.
Methods: We examined 2,368 patients in the BARI 2D trial who underwent ABI assessment at baseline. Death and major cardiovascular events (death, myocardial infarction and stroke) during follow-up (average 4.3 years) were assessed across the ABI spectrum and by categorized ABI: low (≤0.90), normal (0.91-1.3), high (>1.3), or noncompressible.
Results: A total of 12,568 person-years were available for mortality analysis. During follow-up, 316 patients died, and 549 had major cardiovascular events. After adjustment for potential confounders, with normal ABI as the referent group, a low ABI conferred an increased risk of death (relative risk [RR] 1.6, CI 1.2-2.2, P = .0005) and major cardiovascular events (RR 1.4, CI 1.1-1.7, P = .004). Patients with a high ABI had similar outcomes as patients with a normal ABI, but risk again increased in patients with a noncompressible ABI with a risk of death (RR 1.9, CI 1.3-2.8, P = .001) and major cardiovascular event (RR 1.5, CI 1.1-2.1, P = .01).
Conclusions: In patients with coronary artery disease and type 2 diabetes, ABI screening and identification of ABI abnormalities including a low ABI (<1.0) or noncompressible artery provide incremental prognostic information.
Copyright © 2012 Mosby, Inc. All rights reserved.
Figures


Similar articles
-
The combination of the ankle brachial index and brachial ankle pulse wave velocity exhibits a superior association with outcomes in diabetic patients.Intern Med. 2014;53(21):2425-31. doi: 10.2169/internalmedicine.53.2999. Epub 2014 Nov 1. Intern Med. 2014. PMID: 25365999
-
Low ankle-brachial index predicts cardiovascular risk after acute ischemic stroke or transient ischemic attack.Stroke. 2009 Dec;40(12):3700-5. doi: 10.1161/STROKEAHA.109.559740. Epub 2009 Oct 15. Stroke. 2009. PMID: 19834020
-
The prevalence and predictors of an abnormal ankle-brachial index in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Diabetes Care. 2011 Feb;34(2):464-7. doi: 10.2337/dc10-1734. Diabetes Care. 2011. PMID: 21270200 Free PMC article.
-
Prognostic Value of Abnormal Ankle-Brachial Index in Patients With Coronary Artery Disease: A Meta-Analysis.Angiology. 2020 Jul;71(6):491-497. doi: 10.1177/0003319720911582. Epub 2020 Mar 13. Angiology. 2020. PMID: 32166959 Review.
-
Predictive value of abnormal ankle-brachial index in patients with diabetes: A meta-analysis.Diabetes Res Clin Pract. 2021 Apr;174:108723. doi: 10.1016/j.diabres.2021.108723. Epub 2021 Feb 27. Diabetes Res Clin Pract. 2021. PMID: 33647330 Review.
Cited by
-
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review.Diabetes Ther. 2024 Sep;15(9):1893-1961. doi: 10.1007/s13300-024-01606-6. Epub 2024 Jul 18. Diabetes Ther. 2024. PMID: 39023686 Free PMC article. Review.
-
Prediction of all-cause and cardiovascular mortality using ankle-brachial index and brachial-ankle pulse wave velocity in patients with type 2 diabetes.Sci Rep. 2022 Jun 30;12(1):11053. doi: 10.1038/s41598-022-15346-9. Sci Rep. 2022. PMID: 35773381 Free PMC article.
-
Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.Diabetologia. 2017 Oct;60(10):1883-1891. doi: 10.1007/s00125-017-4344-x. Epub 2017 Jul 5. Diabetologia. 2017. PMID: 28681124
-
Prognostic impact of the ankle-brachial index on the development of micro- and macrovascular complications in individuals with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.Diabetologia. 2018 Nov;61(11):2266-2276. doi: 10.1007/s00125-018-4709-9. Epub 2018 Aug 15. Diabetologia. 2018. PMID: 30112690
-
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2. Cochrane Database Syst Rev. 2018. PMID: 30246878 Free PMC article.
References
-
- Adler AI, Boyko EJ, Ahroni JH, et al. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999;22:1029–1035. - PubMed
-
- Norman PE, Davis WA, Bruce DG, et al. Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2006;29:575–580. - PubMed
-
- O'Hare AM, Katz R, Shlipak MG, et al. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006;113:388–393. - PubMed
-
- Ono K, Tsuchida A, Kawai H, et al. Ankle-brachial blood pressure index predicts all-cause and cardiovascular mortality in hemodialysis patients. J Am SocNeph. 2003;14:1591–1598. - PubMed
-
- Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109:733–739. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical